loadpatents
Patent applications and USPTO patent grants for Societe de Conseils de Recherches et D'Applications Scientifiques, SAS.The latest application filed is for "glp-1 pharmaceutical compositions".
Patent | Date |
---|---|
Analogs of parathyroid hormone Grant 7,632,811 - Dong December 15, 2 | 2009-12-15 |
Somatostatin-dopamine chimeric analogs Grant 7,579,435 - Culler , et al. August 25, 2 | 2009-08-25 |
Somatostatin-dopamine chimeric analogs Grant 7,572,883 - Culler , et al. August 11, 2 | 2009-08-11 |
Imidazolyl derivatives Grant 7,566,734 - Thurieau , et al. July 28, 2 | 2009-07-28 |
Analogs of parathyroid hormone Grant RE40,850 - Dong July 14, 2 | 2009-07-14 |
PTH2 receptor selective compounds Grant 7,531,621 - Dong , et al. May 12, 2 | 2009-05-12 |
GLP-1 pharmaceutical compositions Grant 7,521,527 - Dong , et al. April 21, 2 | 2009-04-21 |
Growth hormone releasing peptides Grant 7,456,253 - Dong November 25, 2 | 2008-11-25 |
Safety injection device for a liquid or semi-solid composition Grant 7,445,612 - Cherif-Cheikh November 4, 2 | 2008-11-04 |
Analogs of parathyroid hormone Grant 7,410,948 - Dong August 12, 2 | 2008-08-12 |
GLP-1 analogues Grant 7,368,427 - Dong , et al. May 6, 2 | 2008-05-06 |
Prenyl transferase inhibitors Grant 7,361,656 - Gordon , et al. April 22, 2 | 2008-04-22 |
Farnesyl transferase inhibitors Grant 7,323,484 - Gordon , et al. January 29, 2 | 2008-01-29 |
GLP-1 pharmaceutical compositions App 20070244034 - Dong; Zheng Xin ;   et al. | 2007-10-18 |
Somatostatin and somatostatin agonists for treating insulin insensitivity and Syndrome X Grant 7,256,174 - Cawthorne , et al. August 14, 2 | 2007-08-14 |
Urotensin-II agonists and antagonists Grant 7,241,737 - Coy , et al. July 10, 2 | 2007-07-10 |
Method of inhibiting fibrosis with a somatostatin agonist Grant 7,238,666 - Culler , et al. July 3, 2 | 2007-07-03 |
Imidazolyl derivatives Grant 7,238,695 - Thurieau , et al. July 3, 2 | 2007-07-03 |
Analogues of GLP-1 Grant 7,235,628 - Dong June 26, 2 | 2007-06-26 |
Use of botuline toxin to obtain a product to be used in articular pathologies, particularly coxarthrosis, epicondylitis and rotator muscle cap pathology Grant 7,208,166 - Marchini , et al. April 24, 2 | 2007-04-24 |
Lactone bearing absorbable polymers Grant 7,205,378 - Ignatious April 17, 2 | 2007-04-17 |
Use of botulinum toxin for treatment of articular pathologies App 20070020294 - Marchini; Corrado ;   et al. | 2007-01-25 |
Somatostatin agonists Grant 7,144,859 - Sadat-Aalaee , et al. December 5, 2 | 2006-12-05 |
Sustained release formulation of a peptide Grant 7,109,166 - Moreau September 19, 2 | 2006-09-19 |
Somatostatin analog and uses thereof Grant 7,094,753 - Gordon , et al. August 22, 2 | 2006-08-22 |
Prenyl transferase inhibitors Grant 7,084,135 - Gordon , et al. August 1, 2 | 2006-08-01 |
Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof Grant 7,084,117 - Culler , et al. August 1, 2 | 2006-08-01 |
Use of Ginkgo extract Grant 7,078,434 - Drieu , et al. July 18, 2 | 2006-07-18 |
Somatostatin and somatostatin agonists for decreasing body weight Grant 7,034,003 - Cawthorne , et al. April 25, 2 | 2006-04-25 |
Method and compositions for treating hyperlipidemia and other conditions Grant 7,026,289 - Cawthorne , et al. April 11, 2 | 2006-04-11 |
Farnesyl transferase inhibitors Grant 7,022,704 - Gordon , et al. April 4, 2 | 2006-04-04 |
Analogs of parathyroid hormone Grant 6,921,750 - Dong July 26, 2 | 2005-07-26 |
Neuromedin b and somatostatin receptor agonists Grant 6,903,074 - Morgan , et al. June 7, 2 | 2005-06-07 |
Analogues of GLP-1 Grant 6,903,186 - Dong June 7, 2 | 2005-06-07 |
Safety injection device Grant 6,896,670 - Cherif Cheikh May 24, 2 | 2005-05-24 |
Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides Grant 6,867,181 - Shalaby , et al. March 15, 2 | 2005-03-15 |
Somatostatin agonists Grant 6,864,234 - Sadat-Aalaee , et al. March 8, 2 | 2005-03-08 |
Imidazolyl derivatives Grant 6,852,725 - Thurieau , et al. February 8, 2 | 2005-02-08 |
Method of inhibiting fibrosis with a somatostatin agonist Grant 6,787,521 - Culler , et al. September 7, 2 | 2004-09-07 |
Inhibition of amylin release Grant 6,774,109 - Dunmore , et al. August 10, 2 | 2004-08-10 |
Somatostatin antagonists App 20040097418 - Coy, David H. ;   et al. | 2004-05-20 |
Somatostatin antagonists Grant 6,703,481 - Coy , et al. March 9, 2 | 2004-03-09 |
Farnesyl transferase inhibitors Grant 6,673,927 - Gordon , et al. January 6, 2 | 2004-01-06 |
Analogs of parathyroid hormone Grant 6,544,949 - Dong April 8, 2 | 2003-04-08 |
Method of identifying pharmaceuticals from plant extracts App 20030026857 - Beaufour, Albert ;   et al. | 2003-02-06 |
Imidazolyl derivatives Grant 6,509,336 - Dong , et al. January 21, 2 | 2003-01-21 |
Imidazolyl derivatives Grant 6,420,555 - Dong , et al. July 16, 2 | 2002-07-16 |
Methods and apparatus for the delivery of solid drug compositions Grant 6,306,420 - Cheikh October 23, 2 | 2001-10-23 |
Encapsulation of water soluble peptides Grant 6,270,700 - Ignatious August 7, 2 | 2001-08-07 |
Peptide analogues Grant 6,242,563 - Dong June 5, 2 | 2001-06-05 |
Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides Grant 6,221,958 - Shalaby , et al. April 24, 2 | 2001-04-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.